These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3289039)

  • 21. Catecholamines and vasopressin during critical illness.
    Asfar P; Hauser B; Radermacher P; Matejovic M
    Crit Care Clin; 2006 Jan; 22(1):131-49, vii-viii. PubMed ID: 16399024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatorenal syndrome.
    Bataller R; Arroyo V; Ginès P; Sort P
    Forum (Genova); 1998; 8(1):62-81. PubMed ID: 9565447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous therapeutic epinephrine but not norepinephrine prolongs splanchnic IL-6 production in porcine endotoxic shock.
    Bergmann M; Gornikiewicz A; Tamandl D; Exner R; Roth E; Függer R; Götzinger P; Sautner T
    Shock; 2003 Dec; 20(6):575-81. PubMed ID: 14625484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of splanchnic circulation: which relevance?
    De Backer D; Creteur J
    Acta Gastroenterol Belg; 2003; 66(4):288-9. PubMed ID: 14989051
    [No Abstract]   [Full Text] [Related]  

  • 25. Vasoactive drugs in shock: the great disillusion.
    Perey BJ
    Can J Surg; 1971 Sep; 14(5):295. PubMed ID: 5113533
    [No Abstract]   [Full Text] [Related]  

  • 26. Diltiazem counteracts digitalis-dependent splanchnic vasoconstriction in man.
    Gasic S; Korn A; Eichler HG
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):553-7. PubMed ID: 3429059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDF: its participation in the pathophysiology of shock.
    Okada K; Kosugi I; Tanokura Y; Tajimi K; Ohmura A; Innami H; Tsukamoto T; Inaba T
    Prog Clin Biol Res; 1983; 111():125-46. PubMed ID: 6867021
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative effects of verapamil, tiapamil, diltiazem and nifedipine on systemic and splanchnic hemodynamics in man.
    Gasic S; Eichler HG; Korn A
    Int J Clin Pharmacol Ther Toxicol; 1987 Sep; 25(9):498-503. PubMed ID: 3679621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pathogenesis and current treatment of shock studied from the aspects of the peripheral circulation and metabolism].
    Hayashi S; Ishiyama K; Tamakuma M; Koizumi S; Nakayama N
    Shujutsu; 1967 Dec; 21(12):1222-33. PubMed ID: 5598670
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of thromboxane biosynthesis in splanchnic ischemia shock.
    Oei HH; Zoganas HC; Sakane Y; Robson RD; Glenn TM
    Circ Shock; 1986; 18(2):95-106. PubMed ID: 3753907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatorenal syndrome.
    Biswas KD; Jain AK
    Trop Gastroenterol; 2002; 23(3):113-6. PubMed ID: 12693150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacological basis of the treatment of shock].
    Faucon G; Evreux JC
    Actual Pharmacol (Paris); 1969; 22():19-84. PubMed ID: 4927119
    [No Abstract]   [Full Text] [Related]  

  • 33. Vasoactive drugs and the gut: is there anything new?
    Woolsey CA; Coopersmith CM
    Curr Opin Crit Care; 2006 Apr; 12(2):155-9. PubMed ID: 16543793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Microcirculation: its participation in shock].
    Birolini D; Martins LC; Tullio J; Bastos BV; Ferreira MC; Ferreira EA; Branco PD; de Oliveira MR
    Rev Assoc Med Bras; 1967 Sep; 13(9):305-12. PubMed ID: 4896586
    [No Abstract]   [Full Text] [Related]  

  • 35. The effects of steroids on splanchnic perfusion in hemorrhagic shock.
    Tuggle DW; Horton JW
    Curr Surg; 1985; 42(5):388-92. PubMed ID: 4053682
    [No Abstract]   [Full Text] [Related]  

  • 36. Recommendations for the treatment of patients with septic shock.
    Meier-Hellmann A; Reinhart K
    Acta Anaesthesiol Scand Suppl; 1997; 111():177-80. PubMed ID: 9421002
    [No Abstract]   [Full Text] [Related]  

  • 37. Release of vasoactive hormones and circulatory changes in shock.
    Wilson MF; Brackett DJ
    Circ Shock; 1983; 11(3):225-34. PubMed ID: 6360411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension.
    Bernadich C; Bandi JC; Melin P; Bosch J
    Hepatology; 1998 Feb; 27(2):351-6. PubMed ID: 9462630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased inotropic state during splanchnic artery occlusion shock in the dog.
    Kober PM; Gibbons DA; Raymond RM
    Circ Shock; 1987; 21(2):97-110. PubMed ID: 3829331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The dilemma of vasopressors and vasodilators in the therapy of shock.
    Shoemaker WC; Brown RS
    Surg Gynecol Obstet; 1971 Jan; 132(1):51-7. PubMed ID: 5538813
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.